Related Experiment Video
Updated: Jul 19, 2025
05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
283
Polysubstance Use in Pregnancy: Surveillance, Interventions, and Next Steps
Youngjoo Park1,2, Elizabeth P Dang1, Amy Board1
1National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Journal of Women'S Health (2002)
|August 8, 2023
Summary
Polysubstance use during pregnancy poses risks to maternal and infant health. The Centers for Disease Control and Prevention (CDC) identified gaps in surveillance, screening, and prevention to improve outcomes.
Area of Science:
- Public Health
- Maternal-Child Health
- Substance Use Disorders
Background:
- Substance use during pregnancy is linked to adverse maternal and neonatal outcomes.
- Polysubstance use is prevalent but its risks during pregnancy are not well understood.
- Understanding combined substance exposures is critical for effective interventions.
Purpose of the Study:
- To review Centers for Disease Control and Prevention (CDC) activities addressing polysubstance use in pregnancy.
- To identify gaps in surveillance, routine screening, and prevention strategies.
- To highlight the importance of addressing polysubstance use for improved maternal and infant health.
Main Methods:
- Overview of CDC and partner activities.
- Identification of knowledge and programmatic gaps.
- Literature review on polysubstance use during pregnancy.
Main Results:
- Gaps exist in surveillance systems for tracking polysubstance use in pregnant individuals.
- Routine screening for polysubstance use is not consistently implemented.
- Prevention efforts require enhanced strategies to address combined substance exposures.
Conclusions:
- Addressing identified gaps in surveillance, screening, and prevention is crucial.
- Collaborative efforts are needed to reduce polysubstance use during pregnancy.
- Interventions can improve health outcomes for pregnant people and their infants.
Related Concept Videos
01:24Substance Use Disorders Affecting Sleep
196
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
196
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
338
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
338
01:19Pharmacovigilance
890
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
890
01:28Drug Therapy
69
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
69
01:17Drug Dependence
1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
01:15Drug Abuse and Addiction: Pharmacological Phenomena
515
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
515